The present study documents that stabilization of bcatenin is sucient to induce lesions reminiscent of prostate intraepithelial neoplasia (PIN). Such lesions were present in all compound mutant mice and all prostate acini expressing stabilized b-catenin. High grade PIN-like lesions resembling early human prostate cancer were detected as early as 10 weeks of age. Surprisingly, stabilization of b-catenin in other secretory epithelia including salivary, preputial, harderian, and mammary glands induced extensive squamous metaplasia and keratinization associated with terminal dierentiation of the target cells, but failed to cause neoplastic transformation. Epidermal hyperplasia, hair follicle cysts, and odontomas were also observed. The prostatic lesions exhibited upregulation of c-myc, increased rate of cellular proliferation, loss of the Na-K-Cl co-transporter NKCC1, and expression of androgen receptor. Basal cell markers such as p63 and keratin 5 were not expressed by the masses of PIN-like lesions, but were present in small foci of proliferating b-catenin expressing basal cells. Our observations indicate that b-catenin stabilization is a crucial event for the initiation of PIN-like lesions, but induces squamous metaplasia rather than tumorigenesis in secretory epithelia other than the prostate.
Introduction
Stabilization b-catenin is associated with the genesis of colorectal neoplasms (Harada et al., 1999; Morin et al., 1997; Sparks et al., 1998) , hair follicle tumors (Gat et al., 1998) , and aberrant dierentiation of T lymphocytes (Gounari et al., 2001) . Furthermore, activation of Wnt genes is associated with mammary carcinoma in mice (for review see Li et al., 2000) . Wnt signaling ultimately leads to the stabilization of b-catenin, by preventing its phosphorylation at critical exon 3 encoded serine and threonine residues and its subsequent degradation (for reviews see Bienz and Clevers, 2000; Lau and Clevers, 2001) . It is possible that aberrant b-catenin signaling may contribute to cancer in a wide range of tissues (Reya et al., 2001) .
There is little published data implicating the bcatenin pathway in the etiology of prostate cancer. Circumstantial evidence from studies on subsets of human prostate cancers documents the overexpression of the Wnt-5A (Iozzo et al., 1995) , APC gene mutations (Brewster et al., 1994; Phillips et al., 1994; Suzuki et al., 1994; Watanabe et al., 1996) , and mutations aecting the stability of b-catenin (Chesire et al., 2000; Voeller et al., 1998) in tumors. Deletion of critical sequences of the b-catenin third exon was reported in each of nine separate metastases examined from a single patient, indicating that this mutation may represent an early and perhaps clonal event (Chesire et al., 2000) . While these observations point to the involvement of b-catenin, their almost anecdotal frequency and their retrospective nature leave the signi®cance of the genetic alterations and their relevance to prostate cancer unclear.
To investigate the potential of b-catenin to cause epithelial tumors, we have taken advantage of Catnb +/l 8 x(ex3) (Harada et al., 1999) and MMTV-Cre (Wagner et al., 1997) mice. Catnb +/l 8 x(ex3) mice have the 3rd exon of the b-catenin gene¯anked by loxP sequences, and upon Cre mediated recombination express a dominant stable form of b-catenin. In the compound mutant progeny, targeted recombination was promoted in a range of tissues, including the prostate. Our observations demonstrate that the recombination of a single b-catenin allele results in sucient stabilization of the protein to induce prostate intraepithelial neoplasia (PIN)-like lesions. In agreement with an earlier report focusing on the mammary gland (Miyoshi et al., 2001) , in other tissues this event induced almost exclusively squamous metaplasia and keratinization rather than neoplastic lesions. These observations are in line with a tissue speci®c mode of action of b-catenin, highlighting the prostate as a target of neoplastic transformation by this signaling pathway.
Results

Targeted excision of b-catenin exon-3 in the mouse prostate
To examine the tissue distribution of Cre, adult (MMTV ± Cre) mice (Wagner et al., 1997) were crossed to (R26R) lacZ reporter mice (Soriano, 1999) .
Cryosections from individual organs of 3-month-old compound mutant male (MMTV ± Cre6R26R) mice were stained for b-galactosidase enzymatic activity. Speci®c mosaic staining of lacZ was detected in the skin, salivary, preputial, harderian, prostate and mammary glands ( Figure 1A , a ± f). Other organs such as the intestine, stomach, and liver did not show speci®c lacZ staining.
Gut speci®c expression of a dominant stable bcatenin has been reported to cause rapid intestinal adenomatous polyps (Harada et al., 1999) . To promote expression of this stabilized form of b-catenin in various tissues, Catnb +/l 8 x(ex3) mice were crossed with MMTV ± Cre transgenic mice. The (MMTV ± Cre6 Catnb +/l 8 x(ex3) ) compound mutant progeny was easy to distinguish because of the smaller size of the newborn pups, cachectic posture, loss of hair, and thickened skin of the adults. The 12% yield of compound mutants (10 male and 11 female/175 total) was signi®cantly below the 25% expected from crossings of simple MMTV ± Cre with simple Catnb +/l 8 x(ex3) mice. Excision of b-catenin exon 3 in (MMTV ± Cre6 Catnb +/l 8 x(ex3) ) mice was followed by Western-blot analysis using b-catenin speci®c mAbs. Detection of a new b-catenin protein species (*85 kDa) con®rmed Cre mediated recombination at the targeted locus. Mutant b-catenin was detected in the skin, salivary, preputial, harderian, and mammary glands ( Figure  1B) , as well as the prostate ( Figure 1C, a) . The stabilized form of b-catenin was absent in prostate protein extracts from control Catnb +/l 8 x(ex3) ( Figure 1B , cont) or MMTV-Cre mice ( Figure 1C, a) . C-myc and cyclin D1 are transcriptional targets of b-catenin in colon carcinoma cells (He et al., 1998; Tetsu and McCormick, 1999) . Prostates from two mice of 16 and 20 weeks of age were used for Western-blot analysis. Expression of c-myc was clearly upregulated in the One property of early neoplastic epithelial cells is the loss of polarization, which is revealed by the loss or reorganization of basolateral or apical markers. Two distinct Na-K-Cl cotransporter isoforms have been identi®ed. The NKCC1 (CCC1, BSC2) isoform is present in a wide variety of secretory epithelia and is localized to the basolateral membrane, while NKCC2 (CCC2, BSC1) is found only in the kidney (Haas and Forbush, 1998) . Expression of the Na-K-Cl co-transporter (NKCC1) was restricted to the basolateral region of prostate secretory epithelial cells (Figure 3b , arrow). Stabilization of b-catenin in the prostate epithelium led to the loss of NKCC1 immuno¯uorescent detection in the (Figure 3d, arrow) . Downregulation of AR in the prostate of compound mutant mice was also observed by Western blot analysis using AR speci®c antibody (not shown). E-cadherin expression, size and subcellular localization was not altered
Aberrations of E-cadherin expression and function have been noted in malignant prostate epithelium (Rashid et al., 2001) . These have been attributed to transcriptional repression of the gene and/or post translational cleavage of the native M r 120 000 Ecadherin (E-Cad 120 ), to a novel cleaved membranebound M r 97 000 fragment ) that lacks the bcatenin binding domain (Rashid et al., 2001) . Western blot analysis of prostate extracts revealed a prominent E-Cad 120 and a weaker E-Cad 97 protein species in both healthy control as well as in diseased compound mutant mice, with no signi®cant dierence between the mice ( Figure 1C, d) . Double immuno¯uorescence analysis for NKCC1 and E-cadherin con®rmed normal localization of E-cadherin at the cell membrane of dysplastic cells within the lesions (Figure 4a ,c, arrowheads) that no longer stained for NKCC1 (Figure 4b ,c, arrowheads). These results suggest that stabilization of b-catenin does not lead to severe disruption of homotypic cell ± cell adhesion, and are in agreement with b-catenin acting at the initiation of the PIN.
Luminal characteristic and increased mitotic activity of the dysplastic cells
Prostate basal cells typically express keratins 5 and 14 (Hayward et al., 1996) as well as p63 (Signoretti et al., 2000) . Basal cell markers, keratin 5 (Figure 4d , arrow) and p63 (Figure 4e ,f, arrows) stained a rim of residual basal cells in the periphery of acini, but were not expressed in the dysplastic epithelium of the PIN-like lesions (Figure 4d,e, arrowheads) . These observations indicate that the lesions either did not have a basal origin or rapidly lost basal cell markers upon stabilization of b-catenin. BrdU staining revealed increased cellular proliferation among the dysplastic cells ( Figure  4g ) (39 dividing cells amongst 540 cells, in four ®elds), while no staining was detected in the prostate of control (Catnb +/lox(ex3) ) mice (no dividing cells detected among over 400 cells in six ®elds). These observations correlate b-catenin stabilization with increased epithelial proliferation and formation of PIN-like lesions.
Interestingly, foci of basal cell hyperplasia consisting of cells expressing both activated b-catenin and keratin 5 were detected. These foci were dicult to score due to their small size, appearing as aggregates of less than 20 cells in the plane of the section. Keratin 5 was downregulated in the foci (Figure 5b , arrowhead) as compared to the adjacent basal cells (Figure 5b, arrow) , and was extinguished in cells protruding in the lumen. Basal cells neighboring the foci stained for keratin 5 (Figure 5b , arrow) but were negative for b-catenin (Figure 5a, arrow) , leaving the possibility open that these may be common progenitors of both basal and secretory cells in transition to a secretory phenotype, with the cells losing basal markers and gaining luminal markers as they enter dysplasia. Another explanation is that the PIN-like lesions originated from the secretory cells.
A relatively infrequent observation was that of squamous keratinized cells and/or keratin debri in the lumen of the acini of compound mutant mice, that stained for keratin 5 (Figure 5c , arrowhead) and/or keratin 1 (Figure 5d ,e, arrowheads; see Figure 5f for HE staining). Squamous metaplasias have been associated with typical adenocarcinomas of the prostate in cases where the patient has undergone extensive estrogen treatment, and may be a rare event in prostate carcinogenesis.
b-catenin stabilization causes epithelial transdifferentiation in multiple organs
Histological examination revealed multiple lesions in other organs that had shown Cre activity as revealed by lacZ staining in MMTV ± Cre6R26R mice. The predominant eect was squamous metaplasia with extensive keratinization. Generalized thickening of the skin, including the paws, ears, lips and eyelids, and patchy loss of hair, gave the mice their characteristic appearance. In agreement with earlier reports (Gat et al., 1998) , we observed thick ridges in skin and hair coat, with marked thickening of the paws and ears. Histologically, the skin showed hyperplasia and Figure 6) . Surprisingly, similar lesions were seen in the salivary gland (Figure 6b , black arrowhead), preputial gland (Figure 6c , black arrowhead), harderian gland (Figure 6d , black arrowhead), and mammary gland (Figure 6e, arrowheads) . We con®rmed earlier observations (Miyoshi et al., 2001) that the mammary glands were severely aected (Figure 6c,e) . The inscissor tooth (Figure 6f , arrow) was surrounded by numerous lobules of dentin, reminiscent of odontoma (Figure 6f, arrowhead) .
Taken together, our observations indicate that stabilization of b-catenin may not be sucient to cause widespread epithelial tumors. The hyperplasia and dysplasia seen in the prostate seems to be an exception rather than the rule. Stabilization of bcatenin is also etiologically linked with colon cancer (Harada et al., 1999; Kinzler and Vogelstein, 1996) . However, since in our compound mutant mice, bcatenin stabilization did not occur in the gut, adenomatous polyps were not observed. Like prostate cancer, squamous metaplasia is not a common feature of colon cancer. These observations suggest that the stabilization of b-catenin may have dierent consequences, depending on the type of epithelial cell targeted, and perhaps also on the immediate environment of target cells.
Discussion
Taken together, our observations indicate that contrary to expectations b-catenin may not have the potential to cause widespread epithelial tumors. On the other hand, the stabilization of b-catenin as a single dominant genetic event is sucient to induce lesions characteristic of prostate intraepithelial neoplasia. Such lesions were present in all compound mutant mice and all prostate acini expressing stabilized b-catenin. Heterogeneous and multifocal lesions resembling high grade human PIN were detected as early as 10 weeks of age. Nevertheless, and contrary to recent speculations (Yang et al., 2002) , there was no convincing evidence for invasion or metastasis by the lesions in mice reaching up to 5 months of age.
Little is known about the mechanisms of initiation of prostate cancer. Histopathological studies of prostate cancers have led to the identi®cation of a speci®c type of lesion that represents the primary precursor of human prostate cancer, known as prostate intraepithelial neoplasia (PIN) (McNeal and Bostwick, 1986) . PIN is recognized as a continuum between low-grade and high-grade forms, with high-grade PIN most likely representing the immediate precursor of early invasive carcinoma. Characteristic architectural and cytological features are shared between PIN lesions and early invasive carcinomas including multifocal nature of the lesions, and common chromosomal abnormalities (reviewed in Abate-Shen and Shen, 2000) . While the observed b-catenin associated lesions reported here have the characteristic appearance of PIN, the association with progression has not been demonstrated. This may be considered as a caveat but we think that it is more likely to re¯ect the speci®c role of b-catenin in the initiation of PIN-like lesions. A similar role for b-catenin has been established in the initiation of intestinal adenomatous polyps, which are considered to be the immediate precursors of invasive carcinoma and colon cancer (Harada et al., 1999; Kinzler and Vogelstein, 1996) . Extensive animal modeling has shown that either the homozygous inactivation of the adenomatous polyposis coli (APC) gene (Fodde et al., 1994; Luongo et al., 1994; Shibata et al., 1997; Takaku et al., 1998) or the stabilization of the b-catenin gene product (Harada et al., 1999) are necessary and sucient to initiate these lesions. A recent re-evaluation of the accumulated histological data has con®rmed that these lesions are not invasive, suggesting that additional genetic changes are required for progression from adenoma to carcinoma (Sundberg, 2000) . Since in our compound mutant mice, b-catenin stabilization did not occur in the gut, adenomatous polyps were not observed. Using mice that express an inducible Cre speci®cally in the gut, we have reproduced results like earlier reports (Harada et al., 1999 ) that activation of b-catenin is sucient for the initiation of adenomatous polyps throughout the intestine (our unpublished results). We did not observe any squamous metaplasia with these intestinal lesions. These observations suggest that the stabilization of bcatenin may have dierent consequences, depending on the type of epithelial cell targeted, and perhaps also on the immediate environment of target cells.
Over expression of Wnt genes is causally linked with mammary carcinogenesis (Li et al., 2000) , as well as some degree of squamous metaplasia in mice (Harold Varmus, personal communication) . We propose that induction of mammary adenocarcinoma in Wnt overexpressing mice requires the engagement of pathways in addition to b-catenin. Our results may appear contradictory to the reported induction of mammary adenocarcinomas in mice over expressing an aminoterminal truncated b-catenin (Imbert et al., 2001) . However, that mouse model diers from ours in the extent of truncation of b-catenin and in its hormone dependent (MMTV-LTR driven) overexpression.
One of the earliest consequences of activation of bcatenin in the prostate epithelium was the apparent loss of NKCC1 expression as revealed by immuno¯uores-cent staining. Two distinct Na-K-Cl cotransporter isoforms have been identi®ed by cDNA cloning and expression. The NKCC1 (CCC1, BSC2) isoform is present in a wide variety of secretory epithelia and is localized to the basolateral membrane, while NKCC2 (CCC2, BSC1) is found only in the kidney (Haas and Forbush, 1998) . We document for the ®rst time the basolateral expression of NKCC1 in the secretory epithelium of healthy mouse prostate, and the rapid loss of detection of this molecule upon stabilization of b-catenin. This loss may re¯ect the loss of epithelial polarity and may be a useful marker for identifying early human prostate cancer lesions.
Stabilization of b-catenin did not alter the membranous localization of E-cadherin. E-cadherin is a transmembrane protein engaged in homotypic cell-cell adhesion (Vasioukhin et al., 2001) . Its cytoplasmic domain interacts with b-catenin, a-catenin, and the actin cytoskeleton, and contributes to tumor suppression by promoting cell adhesion and by competing for the free pool of b-catenin . Adhesion could contribute to tumor suppression by physically joining cells, by facilitating other juxtacrine signaling events, or by binding and antagonizing the nuclear signaling function of b-catenin . Loss of E-cadherin is associated with poor prognosis in human prostate cancer, and thus may be linked to the progression rather than the initiation of the cancer (Bussemakers et al., 2000; Davies et al., 2000) . In our model, the normal localization and strong expression of E-cadherin in the PIN-like lesions correlates with the absence of invasion or metastasis, and with the notion that the action of b-catenin is restricted to the initiation of the PIN lesions. Additional genetic changes are likely to be required to promote the progression of these lesions.
It has been proposed that androgen speci®c signaling via the epithelial (Stanbrough et al., 2001 ) and stromal (Kurita et al., 2001 ) AR regulates the growth and apoptosis of secretory epithelia in healthy prostate. In response to exogenous androgen, b-catenin binds AR, shuttles to the nucleus (Mulholland et al., 2002) , and stimulates androgen dependent transcriptional activation (Truica et al., 2000) . Prostate cancer is an androgen dependent disease that can be treated by androgen ablation therapy. Expression of AR in the bcatenin induced PIN-like lesions indicates that these had characteristics of secretory luminal epithelium, and of human PIN. There is some controversy as to whether the level of AR expression in PINs is downregulated (Magi-Galluzzi et al., 1997) or enhanced (Truica et al., 2000) . In our study, immunohistochemical and Western-blot analysis (not shown) revealed lower steady-state levels of AR in PIN lesions.
The presented information together with earlier studies indicate that the b-catenin pathway is a key regulator of cell fate determination in epithelial cells in general and in a limited number of tissues may be the initiating signal for neoplasia. The interesting question now is to address the tissue speci®city of this choice, namely the genetic factors, signaling, and tissue environmental factors that determine the choice between transdierentiation and pre-neoplasia in dierent tissues.
Materials and methods
Mice Catnb
+/7l 8 x(ex3) (Harada et al., 1999) , MMTV ± Cre (Wagner et al., 1997) , R26R (Soriano, 1999) have been described previously.
Histology
Mice were perfused with 4% paraformaldehyde, and isolated tissues were ®xed in 4% paraformaldehyde for 4 ± 6 h and then transferred to 70% ethanol. Fixed samples were embedded in paran, sectioned at 6 mm, and stained with hematoxylin and eosin.
Antibodies
Primary antibodies: Rabbit polyclonal antibodies against keratin 1 and keratin 5 (BAbco; PRB-165P and PRB-160P); c-myc (Upstate biotechnology, 06-340); E-cadherin (BD Transduction Laboratories, C20820); cyclin D1 (Santa Cruz, sc-593), NKCC1 was a kind gift from RJ Turner (MooreHoon and Turner, 1998). Mouse monoclonal antibodies against b-catenin, p27, and anti-BrdU (BD Transduction Laboratories, C19220, K25020, and 347580), AR (Upstate Biotechnology, PG-21 06-680), b-actin (Chemicon International, Inc., MAB1501). FITC-conjugated anti-mouse (Alexauor 488) and Texas Red-conjugated anti-rabbit (Alexa¯uor 594) secondary antibodies (Molecular Probes) were used for immunohistochemistry and HRP-conjugated anti-mouse and anti-rabbit secondary antibodies were used for Western blotting (Transduction Labs). Further antibodies, used for immunoperoxidase staining, were goat anti-Mouse polyvalent IgG Biotin Conjugate (Super Sensitive MultiLink-BioGenex, HK340-9K) and Peroxidase Conjugated Streptavidin (BioGenex, HK330-9K).
Immunohistology and enzymatic assay and staining for b-galactosidase Immuno¯uorescence staining was as described before (Miyoshi et al., 2001) . Images were visualized by a Nikon E300¯uorescent microscope and recorded with a Spot CCD camera. Immunoperoxidase staining was according to instructions of the kit manufacturer (SS MultiLink Detection Kit, HRP/DAB-BioGenex, QD200-OX). b-galactosidase activity was revealed on 6 mm cryosections as described (Khazaie et al., 1994) .
Western blotting
Protein lysates were prepared in RIPA buer as described in (Gounari et al., 2001) , electrophoresed on 10% SDS ± PAGE and blotted onto nitrocellulose membranes (DCL, Schleicher and Schuel, Dassel, Germany). Primary antibodies were incubated with the membranes for 1 ± 3 h at room temperature, and then incubated with an HRP-linked anti-mouse or anti-rabbit secondary antibody for 30 min at room temperature. The signal was developed using the ECL detection system (Amersham, Little Chalfont, UK).
